Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rena M Conti

Showing results (31-40 of 133) with videos related to

Pageof 14
Sort By:
JAMA Health Forum|October 11, 2022
Projections of US Prescription Drug Spending and Key Policy ImplicationsRena M Conti, Ani Turner, Paul Hughes-Cromwick
JAMA|April 26, 2025
Changes in Inhaled Steroid Dispensing to Children After Withdrawal of Brand-Name Fluticasone PropionateKao-Ping Chua, Anna Volerman, Rena M Conti
The New England Journal of Medicine|November 12, 2021
Regulating Drug Prices while Increasing InnovationRena M Conti, Richard G Frank, Jonathan Gruber
Pediatrics|July 21, 2021
Prescription Drug Dispensing to US Children During the COVID-19 PandemicKao-Ping Chua, Anna Volerman, Rena M Conti
JAMA|June 21, 2019
Pharmacy Benefit Manager Reform: Lessons From OhioTrevor J Royce, Sheetal Kircher, Rena M Conti
Advances in Health Economics and Health Services Research|November 20, 2012
How do initial signals of quality influence the diffusion of new medical products? The case of new cancer drug treatmentsRena M Conti, Arielle Bernstein, David O Meltzer
JAMA Internal Medicine|June 2, 2020
Out-of-Pocket Spending for Insulin, Diabetes-Related Supplies, and Other Health Care Services Among Privately Insured US Patients With Type 1 DiabetesKao-Ping Chua, Joyce M Lee, Rena M Conti
The American Journal of Managed Care|August 18, 2022
Out-of-pocket spending for health care after COVID-19 hospitalizationKao-Ping Chua, Rena M Conti, Nora V Becker
JAMA|January 13, 2022
US Insurer Spending on Ivermectin Prescriptions for COVID-19Kao-Ping Chua, Rena M Conti, Nora V Becker
JAMA Pediatrics|July 28, 2020
Potential Change in Insulin Out-of-Pocket Spending Under Cost-Sharing Caps Among Pediatric Patients With Type 1 DiabetesKao-Ping Chua, Joyce M Lee, Rena M Conti
Pageof 14

Showing results (31-40 of 133) with videos related to

Sort By:
Pageof 14
JAMA Health Forum|October 11, 2022
Projections of US Prescription Drug Spending and Key Policy ImplicationsRena M Conti, Ani Turner, Paul Hughes-Cromwick
JAMA|April 26, 2025
Changes in Inhaled Steroid Dispensing to Children After Withdrawal of Brand-Name Fluticasone PropionateKao-Ping Chua, Anna Volerman, Rena M Conti
The New England Journal of Medicine|November 12, 2021
Regulating Drug Prices while Increasing InnovationRena M Conti, Richard G Frank, Jonathan Gruber
Pediatrics|July 21, 2021
Prescription Drug Dispensing to US Children During the COVID-19 PandemicKao-Ping Chua, Anna Volerman, Rena M Conti
JAMA|June 21, 2019
Pharmacy Benefit Manager Reform: Lessons From OhioTrevor J Royce, Sheetal Kircher, Rena M Conti
Advances in Health Economics and Health Services Research|November 20, 2012
How do initial signals of quality influence the diffusion of new medical products? The case of new cancer drug treatmentsRena M Conti, Arielle Bernstein, David O Meltzer
JAMA Internal Medicine|June 2, 2020
Out-of-Pocket Spending for Insulin, Diabetes-Related Supplies, and Other Health Care Services Among Privately Insured US Patients With Type 1 DiabetesKao-Ping Chua, Joyce M Lee, Rena M Conti
The American Journal of Managed Care|August 18, 2022
Out-of-pocket spending for health care after COVID-19 hospitalizationKao-Ping Chua, Rena M Conti, Nora V Becker
JAMA|January 13, 2022
US Insurer Spending on Ivermectin Prescriptions for COVID-19Kao-Ping Chua, Rena M Conti, Nora V Becker
JAMA Pediatrics|July 28, 2020
Potential Change in Insulin Out-of-Pocket Spending Under Cost-Sharing Caps Among Pediatric Patients With Type 1 DiabetesKao-Ping Chua, Joyce M Lee, Rena M Conti
Pageof 14